Supply Chain

Medline Industries will purchase AngioDynamics' fluid management portfolio for $167.5 million.

Boston Scientific is anticipating a $25 million hit to its 2019 revenue after the FDA ordered device makers to pull surgical pelvic mesh products from the market, according to The Worcester Business Journal.

Citing safety concerns, the FDA has ordered manufacturers of surgical mesh products intended for transvaginal repair of pelvic organ prolapse to stop selling and distributing the products in the U.S.

Earlier this year the Illinois Environmental Protection Agency issued an order that shut down operations at a large sterilization facility in Willowbrook, Ill., owned by Sterigenics. Now, despite the FDA preparing for delays and potential device shortages, several devices are…

Four drugs or medical devices approved by the FDA since April 1:

While novel medical devices offer the promise of advanced treatment options and better outcomes for patients, the high costs associated with the devices and the lagging reimbursement structure create financial challenges for hospitals.

Medical technology maker Metronic and Blue Cross and Blue Shield of Minnesota inked an outcomes-based agreement for Medtronic's glucose monitor, the companies said April 8.

For hospitals and health systems, product variation within surgical packs can lead to inefficiencies and excess spending.

When clinical and supply chain teams have competing priorities and don’t communicate effectively, the resulting supply chain challenges can lead to frustration and impact patient outcomes.

Four recent drugs or medical devices approved by the FDA since March 1: